Aytu BioPharma, Inc. (LON:0A8M)
London · Delayed Price · Currency is GBP · Price in USD 2.200
+0.520 (30.95%)
At close: May 16, 2025
Aytu BioPharma Market Cap
Aytu BioPharma has a market cap or net worth of 17.31 million as of February 6, 2026. Its market cap has increased by 101.53% in one year.
Market Cap
17.31M
Enterprise Value
10.59M
Revenue
46.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.20
Market Cap Chart
Since April 22, 2015, Aytu BioPharma's market cap has decreased from 48.94M to 17.31M, a decrease of -64.64%. That is a compound annual growth rate of -9.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 17.31M | -12.06% |
| Dec 31, 2025 | 19.68M | 135.70% |
| Dec 31, 2024 | 8.35M | -32.73% |
| Dec 29, 2023 | 12.41M | 26.76% |
| Dec 30, 2022 | 9.79M | -65.10% |
| Dec 31, 2021 | 28.06M | -64.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aquila Energy Efficiency Trust | 20.44M |
| Develop North | 19.48M |
| Palatin Technologies | 18.65M |
| Creightons | 18.50M |
| East Star Resources | 18.29M |
| Solvonis Therapeutics | 17.70M |
| Cindrigo Holdings | 17.53M |
| Ground Rents Income Fund | 17.22M |